Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers

Schizophrenia Research

Volumn 155, Issue 1-3, 2014, Pages 26-30

  Fung, Samantha J ^a,b,c   Fillman, Stu G ^a,b,c   Webster, Maree J ^d   Shannon Weickert, Cynthia ^a,b,c  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Stanley Medical Research Institute   (United States)

Author keywords

Calbindin; MRNA; Postmortem; Somatostatin; Vasoactive intestinal peptide

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; CALBINDIN; CALRETININ; CHOLECYSTOKININ; MESSENGER RNA; NEUROPEPTIDE Y; PARVALBUMIN; SOMATOSTATIN; TATA BINDING PROTEIN; UBIQUITIN C; VASOACTIVE INTESTINAL POLYPEPTIDE; BIOLOGICAL MARKER;

ACTB GENE; ADULT; ARTICLE; B2M GENE; BIPOLAR DISORDER; CB GENE; CCK GENE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CR GENE; FEMALE; HUMAN; INTERNEURON; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NPY GENE; ONSET AGE; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PV GENE; SCHIZOPHRENIA; SST GENE; TBP GENE; UBC GENE; VIP GENE; BRAIN CORTEX; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CALBINDINS; CEREBRAL CORTEX; FEMALE; HUMANS; INTERNEURONS; MALE; MIDDLE AGED; RNA, MESSENGER; SCHIZOPHRENIA; SOMATOSTATIN; VASOACTIVE INTESTINAL PEPTIDE; YOUNG ADULT;

EID: 84899481177     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.02.021     Document Type: Article

References (38)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 1995, 52(4):258-266.
2. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 1997, 24(3):349-355.
3. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 1991, 48(11):996-1001.
4. Caberlotto L., Hurd Y.L. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 1999, 10(8):1747-1750.
5. Caletti E., Paoli R.A., Fiorentini A., Cigliobianco M., Zugno E., Serati M., Orsenigo G., Grillo P., Zago S., Caldiroli A., Prunas C., Giusti F., Consonni D., Altamura A.C. Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data. Front. Hum. Neurosci. 2013, 7:661.
6. Catts V.S., Fung S.J., Long L.E., Joshi D., Vercammen A., Allen K.M., Fillman S.G., Rothmond D.A., Sinclair D., Tiwari Y., Tsai S.Y., Weickert T.W., Shannon Weickert C. Rethinking schizophrenia in the context of normal neurodevelopment. Front. Cell. Neurosci. 2013, 7:60.
7. Choi K.H., Elashoff M., Higgs B.W., Song J., Kim S., Sabunciyan S., Diglisic S., Yolken R.H., Knable M.B., Torrey E.F., Webster M.J. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry 2008, 8:87.
8. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., Everall I. The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry 2002, 51(5):377-386.
9. Craddock N., Owen M.J. The Kraepelinian dichotomy - going, going... but still not gone. Br. J. Psychiatry 2010, 196(2):92-95.
10. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 1995, 59(1-2):81-96.
11. Fung S.J., Webster M.J., Sivagnanasundaram S., Duncan C., Elashoff M., Weickert C.S. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am. J. Psychiatry 2010, 167(12):1479-1488.
12. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57(11):1061-1069.
13. Hall M.H., Spencer K.M., Schulze K., McDonald C., Kalidindi S., Kravariti E., Kane F., Murray R.M., Bramon E., Sham P., Rijsdijk F. The genetic and environmental influences of event-related gamma oscillations on bipolar disorder. Bipolar Disord. 2011, 13(3):260-271.
14. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003, 23(15):6315-6326.
15. Hashimoto T., Bazmi H.H., Mirnics K., Wu Q., Sampson A.R., Lewis D.A. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am. J. Psychiatry 2008, 165(4):479-489.
16. Hof P.R., Morrison J.H. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp. Neurol. 1991, 111(3):293-301.
17. Kawaguchi Y., Kubota Y. Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex. J. Neurosci. 1996, 16(8):2701-2715.
18. Knable M.B., Barci B.M., Bartko J.J., Webster M.J., Torrey E.F. Molecular abnormalities in the major psychiatric illnesses: classification and regression tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry 2002, 7(4):392-404.
19. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the stanley neuropathology consortium. Mol. Psychiatry 2004, 9(6):609-620. (544).
20. Konradi C., Yang C.K., Zimmerman E.I., Lohmann K.M., Gresch P., Pantazopoulos H., Berretta S., Heckers S. Hippocampal interneurons are abnormal in schizophrenia. Schizophr. Res. 2011, 131(1-3):165-173.
21. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012, 35(1):57-67.
22. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., Wu C. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 2004, 5(10):793-807.
23. Morris H.M., Hashimoto T., Lewis D.A. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb. Cortex 2008, 18(7):1575-1587.
24. Morris H.M., Stopczynski R.E., Lewis D.A. NPY mRNA expression in the prefrontal cortex: selective reduction in the superficial white matter of subjects with schizoaffective disorder. Schizophr. Res. 2009, 115(2-3):261-269.
25. Pantazopoulos H., Lange N., Baldessarini R.J., Berretta S. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol. Psychiatry 2007, 61(5):640-652.
26. Pi H.J., Hangya B., Kvitsiani D., Sanders J.I., Huang Z.J., Kepecs A. Cortical interneurons that specialize in disinhibitory control. Nature 2013, 6(10). (ePub ahead of print).
27. Sakai T., Oshima A., Nozaki Y., Ida I., Haga C., Akiyama H., Nakazato Y., Mikuni M. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 2008, 28(2):143-150.
28. Sibille E., Morris H.M., Kota R.S., Lewis D.A. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int. J. Neuropsychopharmacol. 2011, 14(6):721-734.
29. Sinclair D., Webster M.J., Fullerton J.M., Weickert C.S. Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder. BMC Psychiatry 2012, 12:84.
30. + and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J. Psychiatry Neurosci. 2011, 36(3):195-203.
31. Thompson M., Weickert C.S., Wyatt E., Webster M.J. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J. Psychiatr. Res. 2009, 43(11):970-977.
32. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 2005, 57(3):252-260.
33. Volk D.W., Lewis D.A. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience 2013, 248C:154-164.
34. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 2000, 57(3):237-245.
35. Wang A.Y., Lohmann K.M., Yang C.K., Zimmerman E.I., Pantazopoulos H., Herring N., Berretta S., Heckers S., Konradi C. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol. 2011, 122(5):615-626.
36. Weickert C.S., Sheedy D., Rothmond D.A., Dedova I., Fung S., Garrick T., Wong J., Harding A.J., Sivagnanansundaram S., Hunt C., Duncan C., Sundqvist N., Tsai S.Y., Anand J., Draganic D., Harper C. Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry 2010, 44(1):59-70.
37. Woo T.U., Shrestha K., Lamb D., Minns M.M., Benes F.M. N-methyl-d-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol. Psychiatry 2008, 64(9):803-809.
38. Zhang Z.J., Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 2002, 55(1-2):1-10.